Clinical Trial Update: Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment [Phase 4]

View source ↗

Summary

This update reports completion of a Phase 4 trial comparing Epzicom versus Truvada for initial once-daily HIV treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epzicom (abacavir/lamivudine)
• TRUVADA (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Sponsor: International Medical Center of Japan | Conditions: HIV Infections | Phase 4 | Status: COMPLETED